30 Mar 23
A small biotech company moved its product into clinical development and needed to complete a phase II study on limited resources before receiving further funding.
tranScrip provided clinical, regulatory, drug safety, and operational support along with internal staff training.
Phase II study completed on time and within budget. Operational systems successfully inspected by MHRA.
Our physicians, scientists and service experts can help to maximise the value of your products. Whatever your project requires, we have the people to meet your needs.